Results 111 to 120 of about 289,373 (313)
Impact of Immunosuppressive Drugs on Patients With Percutaneous Left Atrial Appendage Occlusion
Journal of Cardiovascular Electrophysiology, EarlyView.ABSTRACT Introduction Percutaneous left atrial appendage closure (LAAC) reduces the risk of thromboembolic stroke in patients with non‐valvular atrial fibrillation who cannot tolerate long‐term oral anticoagulation. However, outcomes after LAAC in patients requiring chronic immunosuppressive therapy (IMS) remain unknown. This study aimed to investigate
Daisuke Togashi +7 more
wiley +1 more source
Coronary Spasm Due to Pulsed Field Ablation: A State‐of‐the‐Art Review
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT With the ever‐growing population of patients undergoing cardiac ablation with pulsed electric fields, there is a need to understand secondary effects from the therapy. Coronary artery spasm is one such effect that has recently emerged as the subject of further investigation in electrophysiology literature.
David A. Ramirez +3 more
wiley +1 more source
Pharmacologic approaches against advanced glycation end products (ages) in diabetic cardiovascular disease [PDF]
, 2015 Advanced Glycation End-Products (AGEs) are signaling proteins associated to several vascular and neurological complications in diabetic and non-diabetic patients.
Avtaar Singh, Sanjeet Singh +6 more
core +2 more sources
Coronary In-Stent Restenosis: JACC State-of-the-Art Review.
Journal of the American College of Cardiology, 2022 G. Giustino +7 more
semanticscholar +1 more source
In-Stent Restenosis in the Drug-Eluting Stent Era
Journal of the American College of Cardiology, 2010 The introduction of the drug-eluting stent (DES) proved to be an important step forward in reducing rates of restenosis and target lesion revascularization after percutaneous coronary intervention. However, the rapid implementation of DES in standard practice and expansion of the indications for percutaneous coronary intervention to high-risk patients ...
George Dangas +5 more
openaire +3 more sources
Pacing and Clinical Electrophysiology, EarlyView.ABSTRACT Background and Aims Central venous obstruction (CVO) increases the complexity of pacing interventions, whether it be with device‐associated symptomatic superior vena cava syndrome (SVCS), or by impeding new implants. Endovascular treatment involves the joint expertise of both cardiac pacing and vascular specialists.
Nadeev Wijesuriya +10 more
wiley +1 more source
In Stent Restenosis Predictors after Carotid Artery Stenting
Stroke Research and Treatment, 2010 Purpose. The long-term efficacy of carotid artery stenting is debated. Predictors of stent restenosis are not fully investigated. Our aim was to assess the incidence of long term restenosis after CAS and to identify some predictors of restenosis. Methods.
Mirco Cosottini +7 more
doaj +1 more source
Biodegradable Stents—A New Option for Benign Central Airway Stenosis
Respirology, EarlyView.Airway stenting using conventional stents for benign central airway stenosis has considerable complication rates as well as technical difficulties while placing and removing. Polydioxanone biodegradable stents serve as a feasible alternative for individuals requiring temporary airway support.
Oğuz Karcıoğlu +6 more
wiley +1 more source
Analysis of risk factors for in⁃stent restenosis after proximal vertebral artery stent implantation
Chinese Journal of Contemporary Neurology and Neurosurgery, 2020 Objective To investigate risk factors for in⁃stent restenosis after proximal vertebral artery (VA) stenting. Methods One hundred and fifty⁃five patients underwent balloon⁃expandable stent assisted⁃angioplasty for symptomatic proximal VA stenosis from ...
Jun LU +4 more
doaj
Drug Distribution and Stent Retention of Drug Eluting Stents [PDF]
, 2008 In this paper the examinations of drug eluting coronary stents are shown, such as the morphology of the coatings before expansion, drug distribution, the methodology and the value of stent retention.
Balázs, T. +3 more
core